109 related articles for article (PubMed ID: 24975508)
1. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma.
Zandvliet M; Teske E; Schrickx JA
Toxicol In Vitro; 2014 Dec; 28(8):1498-506. PubMed ID: 24975508
[TBL] [Abstract][Full Text] [Related]
2. Antitumour effect and modulation of expression of the ABCB1 gene by perifosine in canine lymphoid tumour cell lines.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jul; 201(1):83-90. PubMed ID: 24881508
[TBL] [Abstract][Full Text] [Related]
3. Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein.
Zandvliet M; Teske E; Chapuis T; Fink-Gremmels J; Schrickx JA
J Vet Pharmacol Ther; 2013 Dec; 36(6):583-7. PubMed ID: 23363222
[TBL] [Abstract][Full Text] [Related]
4. Development of multidrug resistance in a canine lymphoma cell line.
Uozurmi K; Nakaichi M; Yamamoto Y; Une S; Taura Y
Res Vet Sci; 2005 Jun; 78(3):217-24. PubMed ID: 15766940
[TBL] [Abstract][Full Text] [Related]
5. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of ABC transporter expression in canine multicentric lymphoma.
Zandvliet M; Teske E; Schrickx JA; Mol JA
Vet J; 2015 Aug; 205(2):263-71. PubMed ID: 25475167
[TBL] [Abstract][Full Text] [Related]
7. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
Caminada D; Zaja R; Smital T; Fent K
Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
[TBL] [Abstract][Full Text] [Related]
8. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
Pop I; Pop L; Vitetta ES; Ghetie MA
Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
[TBL] [Abstract][Full Text] [Related]
10. Induction of chemoresistance in a cultured canine cell line by retroviral transduction of the canine multidrug resistance 1 gene.
Matsuura S; Koto H; Ide K; Fujino Y; Setoguchi-Mukai A; Ohno K; Tsujimoto H
Am J Vet Res; 2007 Jan; 68(1):95-100. PubMed ID: 17199425
[TBL] [Abstract][Full Text] [Related]
11. Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line.
Chen W; Liu I; Tomiyasu H; Lee J; Cheng C; Liao AT; Liu B; Liu C; Lin C
Vet J; 2019 Dec; 254():105398. PubMed ID: 31836165
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric assessment of P-glycoprotein and multidrug resistance-associated protein activity and expression in canine lymphoma.
Poźniak B; Pawlak A; Obmińska-Mrukowicz B
In Vivo; 2015; 29(1):149-53. PubMed ID: 25600546
[TBL] [Abstract][Full Text] [Related]
13. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.
Ma Y; Wink M
Phytomedicine; 2008 Sep; 15(9):754-8. PubMed ID: 18222670
[TBL] [Abstract][Full Text] [Related]
14. Resistant mechanisms of anthracyclines--pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues.
Kubota T; Furukawa T; Tanino H; Suto A; Otan Y; Watanabe M; Ikeda T; Kitajima M
Breast Cancer; 2001; 8(4):333-8. PubMed ID: 11791127
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
[TBL] [Abstract][Full Text] [Related]
16. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
17. IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.
Saaby L; Helms HC; Brodin B
Mol Pharm; 2016 Feb; 13(2):640-52. PubMed ID: 26651362
[TBL] [Abstract][Full Text] [Related]
18. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]